Home
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)

Clinical trial condition

Pancreatic Ductal Adenocarcinoma (PDAC)

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma (PDAC). Study availability and eligibility vary by location and protocol.

68 public trials 39 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma (PDAC) trial results

Recruiting

Nutrition Intervention for Pancreatic Cancer

NCT07554560

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +12 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

NCT07542041

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)

NCT06659705

Conditions: Pancreatic Ductal Adenocarcinoma (PDAC)
Locations: Institut Curie -site Saint-Cloud Saint-Cloud, France

View Trial Details

Recruiting

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

NCT06639724

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of California, San Diego Moores Cancer Center La Jolla, California, United States

View Trial Details

Recruiting

Advanced Therapies for Liver Metastases

NCT04622423

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +20 more
Locations: IRCCS San Raffaele Milan, Italy

View Trial Details

Recruiting

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

NCT07480928

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT06895031

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NCT07227168

Conditions: Cervical Cancer, Colonic Diseases, Colorectal Cancer, +34 more
Locations: SCRI Denver Denver, Colorado, United States

SCRI FCS Sarasota Sarasota, Florida, United States

Mass General Cancer Center Boston, Massachusetts, United States

NEXT Austin Austin, Texas, United States

View Trial Details

Recruiting

Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

NCT07155850

Conditions: Locally Advanced, Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable
Locations: Fondazione Policlinico Universitario A. Gemelli, IRCCS Roma, Italy

Guy's & St Thomas' and Kings College Hospitals London, United Kingdom

View Trial Details

Recruiting

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

NCT07410494

Conditions: Acute Myeloid Leukemia (AML), Adenocarcinoma, Adnexal Diseases, +92 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Pancreatic Ductal Adenocarcinoma (PDAC)

Pancreatic Ductal Adenocarcinoma (PDAC) trial results

Related conditions